SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors closely monitor store expansion and data-driven price optimization, with the community actively debating the timing and impact of a potential relisting on a major exchange. Enthusiasm remains high regarding the company's aggressive growth in China, although sentiment is tempered by ongoing frustration over its OTC listing status and daily price fluctuations.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to a significant uptick in volume and intense social media speculation surrounding potential anchor tenant negotiations, all while the company aggressively pursues expansion milestones like recent turbine deliveries at the Port of Houston. Community sentiment remains polarized, with many users debating whether the stock's recent volatility and capital-raising activities indicate a strategic setup for a major breakout or if the lack of formal partnership updates signals continued downside risk.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is seeing high volatility and intense community discussion following reports of a potential acquisition by NXP Semiconductors, a move seen by many as a strategic play to bolster NXPs automotive AI and edge computing portfolio. While investors are debating the merits of a buyout premium against the uncertainties of such a complex deal, active traders are closely watching the stock's significant volume and technical price swings.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is facing intense downward pressure after FDA briefing documents highlighted ongoing concerns regarding trial design and efficacy, fueling widespread community speculation that the company will receive a third rejection ahead of its upcoming advisory committee meeting. Investors are heavily debating the firm's cash runway and potential for significant dilution, with many retail participants warning of a 'trap' while traders focus on the volatility leading up to the final regulatory decision.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and intense community discussion surrounding its recent leadership transition to CEO Michael Severino, with investors debating whether this signals a potential turnaround or a shift away from imminent buyout hopes. While some in the community highlight the stock's deep valuation discount relative to its revenue and commercial pipeline, others remain frustrated by persistent downward price pressure and the company's struggle to maintain positive momentum despite sector-wide movements.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors react to a positive second-quarter earnings report, which featured a double beat on top and bottom-line estimates and raised full-year guidance. The community is actively discussing the stock's significant short interest, recent analyst price target upgrades, and a broader bullish sentiment driven by strong ABS issuance and the company's ability to maintain profitability despite macroeconomic uncertainty.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing significant momentum as investors digest the recent EU approval for its oral Wegovy pill, which is being widely viewed as a major competitive advantage over Eli Lilly in the rapidly expanding oral GLP-1 market. While the stock continues to navigate legal headlines and trial-related noise, community sentiment remains heavily focused on the company's strong prescription growth and its ability to scale manufacturing for the highly anticipated shift toward oral weight-management treatments.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is capturing significant investor attention as it navigates complex legal battles over its California pipeline restart and federal authority. The community is focused on the potential for federal intervention, such as Defense Production Act support or strategic reserve designation, to catalyze a major revaluation while they closely watch upcoming court rulings and the pending refinancing of debt.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD is trending as investors weigh strong earnings growth and deep-value metrics against regulatory headlines regarding e-commerce subsidies. The community remains divided, with many debating if recent price action represents an accumulation opportunity for long-term holding or a persistent value trap.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is seeing significant volatility as investors digest a disappointing earnings report, reduced dividend payouts, and concerns over the company's private credit and CLO strategy. The community remains deeply divided, with some investors debating management's long-term transparency and the sustainability of the fund's net asset value, while others discuss the potential for a rebound driven by high yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
